Table 2. Overview of Cifdofovir dose levels and DLTs observed in treated patients.
Dose (mg) | Treated patients (N) | Patients evaluable for DLT (N) | Occurrence of DLT (N) |
---|---|---|---|
1 | 3 | 3 | 0 |
2.5 | 3 | 3 | 0 |
5 | 3 | 3 | 0 |
6.5 | 6 | 6 | 2 |
Total | 15 | 15 | 2 |
DLT: dose-limiting toxicity ; N: number of patients.